GlassScriptPhysician profile
Andrew Jawa
NPI 1568671188
$2,564,273.49
in general payments reported to CMS, 2019-2025
27 companies · $789K in 2025
The $789K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $7,563 · 2021: $477K · 2022: $390K · 2023: $430K · 2024: $401K · 2025: $789K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.5M · Consulting Fee: $125K · Travel and Lodging: $2,802 · Food and Beverage: $2,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,489,771.18 |
| Consulting Fee | $124,640.00 |
| Travel and Lodging | $2,801.72 |
| Food and Beverage | $2,616.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $1,182,999.56 | 2021-2025 | Inhance, Na |
| Ignite Orthopedics, LLC | $1,144,882.39 | 2019-2025 | |
| Medical Device Business Services, INC. | $157,876.14 | 2019-2025 | Inhance, Attune |
| Encore Medical, LP | $74,474.82 | 2019-2024 | Djo Surgical |
| Exactech, INC. | $498.90 | 2025 | |
| Kci USA, INC. | $400.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $376.19 | 2022-2025 | Zilretta, Iovera, Exparel |
| Stryker Corporation | $359.95 | 2021-2022 | |
| Smith+Nephew, INC. | $301.96 | 2021-2023 | N/A |
| Zurimed Technologies INC. | $247.28 | 2025 | Fiberlocker System |
| Zimmer Biomet Holdings, INC. | $186.92 | 2025 | Comprehensive Shoulder System |
| Linvatec Corporation | $185.11 | 2023 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $179.07 | 2019-2024 | Monovisc, Orthovisc |
| Miach Orthopaedics, INC. | $170.50 | 2022 | |
| Catalyst Orthoscience | $163.03 | 2022-2024 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $152.96 | 2023 | |
| Bone Support INC. | $143.65 | 2024 | Ceramentbone Void Filler, Cerament G |
| Innovation Technologies INC | $119.29 | 2021 | |
| Avanos Medical | $116.79 | 2021 | |
| Baxter Healthcare | $115.38 | 2025 | Floseal |
| Acumed LLC | $82.89 | 2020 | |
| Orthofix Medical, INC. | $65.15 | 2021-2023 | Physio-Stim |
| Biotissue Holdings INC. | $49.89 | 2024 | |
| Ferring Pharmaceuticals INC. | $41.24 | 2024 | Euflexxa |
| Pacira Therapeutics, INC. | $39.26 | 2020-2021 | |
| Bioventus LLC | $23.22 | 2022 | |
| Heron Therapeutics, INC. | $21.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,591,978.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Jawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.